Startseite
XT

Xavier Tekpli

351
27
4

Ausbildung

  • INSERM U620
    Abschluss PhD student
    Startdatum 01/2005
    Enddatum 01/2009
  • University of Rennes
    Abschluss PhD of Biology: Early event in B[a]P-induced apoptosis: involvement of plasma membrane remodeling in
    Studienrichtung INSERM U620
    Startdatum 01/2005
    Enddatum 01/2009
    Beschreibung PhD of Biology: Early event in B[a]P-induced apoptosis: involvement of plasma membrane remodeling in the regulation of intracellular pH and intercellular communication
  • Master degree of Biology: functional genomics and health
    Abschluss Master
    Studienrichtung University of Rennes
    Startdatum 01/2004
    Enddatum 01/2005
  • Master degree of Cellular Biology and Physiology: Cellular and Molecular Genetics,
    Abschluss Master
    Studienrichtung University of Rennes
    Startdatum 01/2003
    Enddatum 01/2004
  • Master degree of Cellular Biology and Physiology: Physiology
    Abschluss Master
    Studienrichtung University of Rennes
    Startdatum 01/2002
    Enddatum 01/2003

Berufserfahrung

OU

Project Leader

Oslo University Hospital •

01/2019 – 01/2025 •

Deaprtment of Medical Genetics

OU

Postdoctoral Fellow

Oslo University Hospital •

01/2015 – 01/2019 •

Institute of Cancer Research, Department of Cancer Genetics

CF

Posatdoctoral fellow

Centre for Molecular Medicine Norway •

01/2012 – 01/2015 •

Stem cell group

NI

Postdoctoral Fellow

National Institute of Occupational Health •

01/2009 – 01/2012 •

Chemical and Biological Work Environment

Xavier Tekpli — Group Leader | PharmaCountry